nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—SIK1—nephron tubule—membranous glomerulonephritis	0.0493	0.0967	CbGeAlD
Dabrafenib—RAF1—EPO Receptor Signaling—PTPRU—membranous glomerulonephritis	0.0448	0.0914	CbGpPWpGaD
Dabrafenib—SIK1—kidney—membranous glomerulonephritis	0.0433	0.0849	CbGeAlD
Dabrafenib—SIK1—cortex of kidney—membranous glomerulonephritis	0.0422	0.0827	CbGeAlD
Dabrafenib—RAF1—nephron tubule—membranous glomerulonephritis	0.0393	0.0769	CbGeAlD
Dabrafenib—RAF1—epithelium—membranous glomerulonephritis	0.0385	0.0754	CbGeAlD
Dabrafenib—SLC22A6—nephron tubule—membranous glomerulonephritis	0.0381	0.0747	CbGeAlD
Dabrafenib—RAF1—kidney—membranous glomerulonephritis	0.0345	0.0676	CbGeAlD
Dabrafenib—RAF1—cortex of kidney—membranous glomerulonephritis	0.0336	0.0659	CbGeAlD
Dabrafenib—SLC22A6—cortex of kidney—membranous glomerulonephritis	0.0326	0.0639	CbGeAlD
Dabrafenib—SLCO1B1—kidney—membranous glomerulonephritis	0.0258	0.0506	CbGeAlD
Dabrafenib—SLC22A8—nephron tubule—membranous glomerulonephritis	0.0228	0.0447	CbGeAlD
Dabrafenib—SLC22A8—kidney—membranous glomerulonephritis	0.0201	0.0393	CbGeAlD
Dabrafenib—SLC22A8—cortex of kidney—membranous glomerulonephritis	0.0195	0.0383	CbGeAlD
Dabrafenib—ABCG2—nephron tubule—membranous glomerulonephritis	0.0162	0.0318	CbGeAlD
Dabrafenib—LIMK1—Sema4D induced cell migration and growth-cone collapse—RHOA—membranous glomerulonephritis	0.0157	0.0321	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transport of organic anions—ALB—membranous glomerulonephritis	0.0147	0.03	CbGpPWpGaD
Dabrafenib—CYP2C8—kidney—membranous glomerulonephritis	0.0147	0.0288	CbGeAlD
Dabrafenib—LIMK1—Sema4D in semaphorin signaling—RHOA—membranous glomerulonephritis	0.0143	0.0292	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—PTPRU—membranous glomerulonephritis	0.0116	0.0236	CbGpPWpGaD
Dabrafenib—SLCO1B3—Recycling of bile acids and salts—ALB—membranous glomerulonephritis	0.0109	0.0223	CbGpPWpGaD
Dabrafenib—LIMK1—G13 Signaling Pathway—RHOA—membranous glomerulonephritis	0.0107	0.0218	CbGpPWpGaD
Dabrafenib—LIMK1—EPHB-mediated forward signaling—RHOA—membranous glomerulonephritis	0.0102	0.0209	CbGpPWpGaD
Dabrafenib—CYP3A4—kidney—membranous glomerulonephritis	0.00994	0.0195	CbGeAlD
Dabrafenib—SLCO1B1—Transport of organic anions—ALB—membranous glomerulonephritis	0.00989	0.0202	CbGpPWpGaD
Dabrafenib—LIMK1—RhoA signaling pathway—RHOA—membranous glomerulonephritis	0.0095	0.0194	CbGpPWpGaD
Dabrafenib—ABCB1—nephron tubule—membranous glomerulonephritis	0.00801	0.0157	CbGeAlD
Dabrafenib—ABCB1—epithelium—membranous glomerulonephritis	0.00785	0.0154	CbGeAlD
Dabrafenib—RAF1—Fc-epsilon receptor I signaling in mast cells—PLA2G1B—membranous glomerulonephritis	0.00773	0.0158	CbGpPWpGaD
Dabrafenib—LIMK1—CXCR4-mediated signaling events—HLA-DRB1—membranous glomerulonephritis	0.00746	0.0152	CbGpPWpGaD
Dabrafenib—SLCO1B1—Recycling of bile acids and salts—ALB—membranous glomerulonephritis	0.00733	0.015	CbGpPWpGaD
Dabrafenib—SIK1—TGF-beta Signaling Pathway—RHOA—membranous glomerulonephritis	0.00715	0.0146	CbGpPWpGaD
Dabrafenib—ABCB1—kidney—membranous glomerulonephritis	0.00704	0.0138	CbGeAlD
Dabrafenib—LIMK1—Semaphorin interactions—RHOA—membranous glomerulonephritis	0.00691	0.0141	CbGpPWpGaD
Dabrafenib—ABCB1—cortex of kidney—membranous glomerulonephritis	0.00685	0.0134	CbGeAlD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—SPARC—membranous glomerulonephritis	0.00594	0.0121	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—C7—membranous glomerulonephritis	0.00586	0.012	CbGpPWpGaD
Dabrafenib—LIMK1—CXCR4-mediated signaling events—RHOA—membranous glomerulonephritis	0.00577	0.0118	CbGpPWpGaD
Dabrafenib—CYP2C8—Arachidonic acid metabolism—TBXAS1—membranous glomerulonephritis	0.00572	0.0117	CbGpPWpGaD
Dabrafenib—SLCO1B3—Bile acid and bile salt metabolism—ALB—membranous glomerulonephritis	0.0057	0.0116	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—membranous glomerulonephritis	0.00546	0.0111	CbGpPWpGaD
Dabrafenib—LIMK1—EPH-Ephrin signaling—RHOA—membranous glomerulonephritis	0.00527	0.0108	CbGpPWpGaD
Dabrafenib—BRAF—B Cell Receptor Signaling Pathway—CD79A—membranous glomerulonephritis	0.00506	0.0103	CbGpPWpGaD
Dabrafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00494	0.0101	CbGpPWpGaD
Dabrafenib—RAF1—BCR signaling pathway—CD79A—membranous glomerulonephritis	0.00471	0.00961	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—CFH—membranous glomerulonephritis	0.00464	0.00948	CbGpPWpGaD
Dabrafenib—LIMK1—CXCR4-mediated signaling events—MMP9—membranous glomerulonephritis	0.00458	0.00935	CbGpPWpGaD
Dabrafenib—LIMK1—EPH-Ephrin signaling—MMP9—membranous glomerulonephritis	0.00419	0.00855	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—SPARC—membranous glomerulonephritis	0.00411	0.00839	CbGpPWpGaD
Dabrafenib—CYP2C8—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00401	0.00818	CbGpPWpGaD
Dabrafenib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.0039	0.00795	CbGpPWpGaD
Dabrafenib—SLCO1B1—Bile acid and bile salt metabolism—ALB—membranous glomerulonephritis	0.00383	0.00782	CbGpPWpGaD
Dabrafenib—BRAF—Signaling events mediated by focal adhesion kinase—RHOA—membranous glomerulonephritis	0.00372	0.0076	CbGpPWpGaD
Dabrafenib—RAF1—PDGF Pathway—RHOA—membranous glomerulonephritis	0.00369	0.00752	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—membranous glomerulonephritis	0.00367	0.00749	CbGpPWpGaD
Dabrafenib—LIMK1—Regulation of Actin Cytoskeleton—RHOA—membranous glomerulonephritis	0.00365	0.00744	CbGpPWpGaD
Dabrafenib—RAF1—B Cell Receptor Signaling Pathway—CD79A—membranous glomerulonephritis	0.0035	0.00715	CbGpPWpGaD
Dabrafenib—BRAF—Signaling events mediated by VEGFR1 and VEGFR2—RHOA—membranous glomerulonephritis	0.00341	0.00697	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—C7—membranous glomerulonephritis	0.00341	0.00696	CbGpPWpGaD
Dabrafenib—RAF1—IL2-mediated signaling events—RHOA—membranous glomerulonephritis	0.00284	0.0058	CbGpPWpGaD
Dabrafenib—RAF1—TWEAK Signaling Pathway—MMP9—membranous glomerulonephritis	0.00276	0.00563	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CFH—membranous glomerulonephritis	0.0027	0.00552	CbGpPWpGaD
Dabrafenib—RAF1—SHP2 signaling—RHOA—membranous glomerulonephritis	0.00268	0.00548	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—RHOA—membranous glomerulonephritis	0.00268	0.00547	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.00265	0.00542	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by focal adhesion kinase—RHOA—membranous glomerulonephritis	0.00258	0.00526	CbGpPWpGaD
Dabrafenib—RAF1—Endothelins—RHOA—membranous glomerulonephritis	0.00251	0.00513	CbGpPWpGaD
Dabrafenib—ABCB1—ABC-family proteins mediated transport—APOA1—membranous glomerulonephritis	0.00242	0.00494	CbGpPWpGaD
Dabrafenib—RAF1—AGE/RAGE pathway—RHOA—membranous glomerulonephritis	0.00242	0.00494	CbGpPWpGaD
Dabrafenib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.0024	0.0049	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by VEGFR1 and VEGFR2—RHOA—membranous glomerulonephritis	0.00236	0.00482	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—SPARC—membranous glomerulonephritis	0.00227	0.00463	CbGpPWpGaD
Dabrafenib—RAF1—Leptin signaling pathway—RHOA—membranous glomerulonephritis	0.00218	0.00446	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.00215	0.00439	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00213	0.00435	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00212	0.00432	CbGpPWpGaD
Dabrafenib—BRAF—PDGFR-beta signaling pathway—RHOA—membranous glomerulonephritis	0.0021	0.00428	CbGpPWpGaD
Dabrafenib—RAF1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—RHOA—membranous glomerulonephritis	0.00207	0.00424	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CD40—membranous glomerulonephritis	0.00207	0.00423	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00204	0.00417	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—IL1B—membranous glomerulonephritis	0.00203	0.00415	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—C7—membranous glomerulonephritis	0.00203	0.00414	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—PLG—membranous glomerulonephritis	0.00201	0.0041	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—RHOA—membranous glomerulonephritis	0.00199	0.00407	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—RHOA—membranous glomerulonephritis	0.00196	0.004	CbGpPWpGaD
Dabrafenib—RAF1—AGE/RAGE pathway—MMP9—membranous glomerulonephritis	0.00192	0.00392	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00189	0.00385	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—RHOA—membranous glomerulonephritis	0.00185	0.00379	CbGpPWpGaD
Dabrafenib—RAF1—Leptin signaling pathway—IL1B—membranous glomerulonephritis	0.00184	0.00376	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—RHOA—membranous glomerulonephritis	0.00182	0.00372	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00182	0.00371	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-DQA1—membranous glomerulonephritis	0.0018	0.00367	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—C3—membranous glomerulonephritis	0.00175	0.00358	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—PLG—membranous glomerulonephritis	0.00172	0.00351	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—RHOA—membranous glomerulonephritis	0.00164	0.00336	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CFH—membranous glomerulonephritis	0.00161	0.00328	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—IL1B—membranous glomerulonephritis	0.00159	0.00325	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CD40LG—membranous glomerulonephritis	0.00159	0.00324	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—MMP9—membranous glomerulonephritis	0.00156	0.00318	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—RHOA—membranous glomerulonephritis	0.00155	0.00317	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD40—membranous glomerulonephritis	0.00151	0.00308	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—RHOA—membranous glomerulonephritis	0.0015	0.00306	CbGpPWpGaD
Dabrafenib—RAF1—PDGFR-beta signaling pathway—RHOA—membranous glomerulonephritis	0.00145	0.00296	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.00142	0.0029	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD79A—membranous glomerulonephritis	0.00142	0.00289	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.00141	0.00288	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—RHOA—membranous glomerulonephritis	0.00141	0.00287	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—IL1B—membranous glomerulonephritis	0.00141	0.00287	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—C3—membranous glomerulonephritis	0.0014	0.00286	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—RHOA—membranous glomerulonephritis	0.0014	0.00285	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—IL1B—membranous glomerulonephritis	0.00139	0.00285	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—RHOA—membranous glomerulonephritis	0.00139	0.00284	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-DQA1—membranous glomerulonephritis	0.00138	0.00283	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—IL1B—membranous glomerulonephritis	0.00137	0.00281	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-DQA1—membranous glomerulonephritis	0.00131	0.00267	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.00128	0.00261	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.00127	0.00259	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—RHOA—membranous glomerulonephritis	0.00126	0.00258	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00122	0.00249	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.00122	0.00248	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—APOA1—membranous glomerulonephritis	0.0012	0.00245	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—C7—membranous glomerulonephritis	0.00118	0.00241	CbGpPWpGaD
Dabrafenib—SLCO1B3—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.00117	0.00239	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—SPARC—membranous glomerulonephritis	0.00117	0.00239	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CD40LG—membranous glomerulonephritis	0.00115	0.00236	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.00114	0.00233	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—MMP9—membranous glomerulonephritis	0.00111	0.00227	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—RHOA—membranous glomerulonephritis	0.00108	0.00221	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.00107	0.00219	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—MMP9—membranous glomerulonephritis	0.00105	0.00214	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—RHOA—membranous glomerulonephritis	0.00104	0.00212	CbGpPWpGaD
Dabrafenib—SLC22A8—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.00104	0.00212	CbGpPWpGaD
Dabrafenib—BRAF—Disease—LRP2—membranous glomerulonephritis	0.00103	0.00211	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—C3—membranous glomerulonephritis	0.00102	0.00208	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—HLA-DRB1—membranous glomerulonephritis	0.000984	0.00201	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—RHOA—membranous glomerulonephritis	0.000973	0.00199	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—IL1B—membranous glomerulonephritis	0.000965	0.00197	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—ALB—membranous glomerulonephritis	0.000952	0.00194	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000951	0.00194	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—TBXAS1—membranous glomerulonephritis	0.000943	0.00192	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CFH—membranous glomerulonephritis	0.000935	0.00191	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000929	0.0019	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—RHOA—membranous glomerulonephritis	0.00092	0.00188	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—PLG—membranous glomerulonephritis	0.000886	0.00181	CbGpPWpGaD
Dabrafenib—SLC22A6—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.000866	0.00177	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD40—membranous glomerulonephritis	0.000859	0.00175	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—LRP2—membranous glomerulonephritis	0.00084	0.00172	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.000832	0.0017	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000817	0.00167	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000817	0.00167	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000809	0.00165	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD79A—membranous glomerulonephritis	0.000808	0.00165	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.0008	0.00163	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000794	0.00162	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000791	0.00161	CbGpPWpGaD
Dabrafenib—SLCO1B1—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.000787	0.00161	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000767	0.00157	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000752	0.00153	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—RHOA—membranous glomerulonephritis	0.000749	0.00153	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DQA1—membranous glomerulonephritis	0.000745	0.00152	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000728	0.00149	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000724	0.00148	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000722	0.00147	CbGpPWpGaD
Dabrafenib—RAF1—Disease—LRP2—membranous glomerulonephritis	0.000716	0.00146	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000701	0.00143	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—RHOA—membranous glomerulonephritis	0.000678	0.00138	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000669	0.00137	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000665	0.00136	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CD40LG—membranous glomerulonephritis	0.000658	0.00134	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1B—membranous glomerulonephritis	0.000641	0.00131	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—TBXAS1—membranous glomerulonephritis	0.000633	0.00129	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000626	0.00128	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—APOA1—membranous glomerulonephritis	0.000619	0.00126	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—C3—membranous glomerulonephritis	0.000606	0.00124	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1B—membranous glomerulonephritis	0.000605	0.00124	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000596	0.00122	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—TBXAS1—membranous glomerulonephritis	0.000587	0.0012	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—C3—membranous glomerulonephritis	0.000582	0.00119	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—LRP2—membranous glomerulonephritis	0.000565	0.00115	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000555	0.00113	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000543	0.00111	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ABCA1—membranous glomerulonephritis	0.000541	0.00111	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP9—membranous glomerulonephritis	0.000538	0.0011	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000537	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000536	0.00109	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000531	0.00108	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	0.00053	0.00108	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000527	0.00108	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—LRP2—membranous glomerulonephritis	0.000523	0.00107	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD40—membranous glomerulonephritis	0.000521	0.00106	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000505	0.00103	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000503	0.00103	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000501	0.00102	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—ALB—membranous glomerulonephritis	0.000491	0.001	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD79A—membranous glomerulonephritis	0.00049	0.001	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—RHOA—membranous glomerulonephritis	0.000483	0.000987	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—RHOA—membranous glomerulonephritis	0.000474	0.000968	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000469	0.000958	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000468	0.000955	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000452	0.000923	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.00044	0.000898	CbGpPWpGaD
Dabrafenib—BRAF—Disease—APOE—membranous glomerulonephritis	0.000438	0.000895	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PLG—membranous glomerulonephritis	0.000434	0.000886	CbGpPWpGaD
Dabrafenib—BRAF—Disease—APOA1—membranous glomerulonephritis	0.000433	0.000885	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000425	0.000867	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000421	0.000859	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.0004	0.000817	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CD40LG—membranous glomerulonephritis	0.000399	0.000815	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—C3—membranous glomerulonephritis	0.000386	0.000789	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP9—membranous glomerulonephritis	0.000384	0.000784	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.000371	0.000756	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—TBXAS1—membranous glomerulonephritis	0.000364	0.000743	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCA1—membranous glomerulonephritis	0.000364	0.000743	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.000361	0.000738	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—APOE—membranous glomerulonephritis	0.000356	0.000727	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—C3—membranous glomerulonephritis	0.000353	0.00072	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—APOA1—membranous glomerulonephritis	0.000352	0.000719	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ABCA1—membranous glomerulonephritis	0.000337	0.000688	CbGpPWpGaD
Dabrafenib—BRAF—Disease—RHOA—membranous glomerulonephritis	0.000332	0.000678	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—C3—membranous glomerulonephritis	0.00033	0.000673	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—LRP2—membranous glomerulonephritis	0.000324	0.000662	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000322	0.000656	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	0.000317	0.000647	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000312	0.000638	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000309	0.00063	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—APOE—membranous glomerulonephritis	0.000307	0.000627	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000305	0.000623	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—APOA1—membranous glomerulonephritis	0.000303	0.00062	CbGpPWpGaD
Dabrafenib—RAF1—Disease—APOE—membranous glomerulonephritis	0.000303	0.000619	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PLG—membranous glomerulonephritis	0.0003	0.000613	CbGpPWpGaD
Dabrafenib—RAF1—Disease—APOA1—membranous glomerulonephritis	0.0003	0.000612	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	0.000283	0.000577	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ALB—membranous glomerulonephritis	0.000279	0.00057	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—RHOA—membranous glomerulonephritis	0.000272	0.000556	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000272	0.000555	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000253	0.000516	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	0.000242	0.000494	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—APOE—membranous glomerulonephritis	0.000239	0.000489	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—APOA1—membranous glomerulonephritis	0.000237	0.000483	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000232	0.000474	CbGpPWpGaD
Dabrafenib—RAF1—Disease—RHOA—membranous glomerulonephritis	0.00023	0.000469	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—C3—membranous glomerulonephritis	0.000228	0.000466	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—APOE—membranous glomerulonephritis	0.000222	0.000452	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—APOA1—membranous glomerulonephritis	0.000219	0.000447	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—APOE—membranous glomerulonephritis	0.000212	0.000434	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—APOA1—membranous glomerulonephritis	0.00021	0.000429	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—membranous glomerulonephritis	0.000209	0.000428	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCA1—membranous glomerulonephritis	0.000209	0.000427	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	0.0002	0.000409	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	0.000195	0.000399	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ALB—membranous glomerulonephritis	0.000187	0.000383	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000185	0.000377	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	0.000182	0.000372	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	0.000174	0.000356	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ALB—membranous glomerulonephritis	0.000174	0.000354	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	0.000168	0.000342	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—RHOA—membranous glomerulonephritis	0.000161	0.000328	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOE—membranous glomerulonephritis	0.000138	0.000281	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—APOA1—membranous glomerulonephritis	0.000136	0.000278	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP9—membranous glomerulonephritis	0.000128	0.000261	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOE—membranous glomerulonephritis	0.00012	0.000245	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	0.000118	0.000242	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	0.000112	0.000229	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ALB—membranous glomerulonephritis	0.000108	0.00022	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—ALB—membranous glomerulonephritis	9.38e-05	0.000192	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	7.38e-05	0.000151	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	7.3e-05	0.000149	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	5.78e-05	0.000118	CbGpPWpGaD
